Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Hilberg

Showing results (251-260 of 274) with videos related to

Pageof 28
Sort By:
Lung|March 12, 2025
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort StudyFrederikke Hjortdahl, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
The European Respiratory Journal|January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthmaMarianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
ERJ Open Research|October 6, 2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
The European Respiratory Journal|December 14, 2019
Eight novel variants in the <i>SLC34A2</i> gene in pulmonary alveolar microlithiasisÅsa Lina M Jönsson, Elisabeth Bendstrup, Susie Mogensen, et al.
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine|June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma RegisterSusanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
Communications Medicine|March 5, 2024
Description of an activity-based enzyme biosensor for lung cancer detectionPaul W Dempsey, Cristina-Mihaela Sandu, Ricardo Gonzalezirias, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pageof 28

Showing results (251-260 of 274) with videos related to

Sort By:
Pageof 28
Lung|March 12, 2025
Supratherapeutic Inhaled Corticosteroid Use in Patients Initiating on Biologic Therapies for Severe Asthma: A Nationwide Cohort StudyFrederikke Hjortdahl, Marianne Baastrup Soendergaard, Susanne Hansen, et al.
The European Respiratory Journal|January 9, 2025
Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthmaMarianne Baastrup Soendergaard, Frederikke Hjortdahl, Susanne Hansen, et al.
ERJ Open Research|October 6, 2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
The European Respiratory Journal|December 14, 2019
Eight novel variants in the <i>SLC34A2</i> gene in pulmonary alveolar microlithiasisÅsa Lina M Jönsson, Elisabeth Bendstrup, Susie Mogensen, et al.
The European Respiratory Journal|November 27, 2025
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthmaKjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, et al.
Respiratory Medicine|June 13, 2025
Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma RegisterSusanne Hansen, Kjell Erik Julius Håkansson, Marianne Baastrup Soendergaard, et al.
Communications Medicine|March 5, 2024
Description of an activity-based enzyme biosensor for lung cancer detectionPaul W Dempsey, Cristina-Mihaela Sandu, Ricardo Gonzalezirias, et al.
BMJ Open Respiratory Research|March 5, 2026
Societal and personal financial burden of severe asthma and impact of biologic therapy: a 19-year nationwide cost analysisKjell E J Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 25, 2025
The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthmaKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pulmonology|July 21, 2025
Financial burden of productivity loss in severe asthma and impact of biologic therapyKjell Erik Julius Håkansson, Rikke Ibsen, Niels Steen Krogh, et al.
Pageof 28